ESR2 and breast carcinoma: While oestrogen treatment of ERα-positive breast cancer cells stimulates proliferation, exogenously introduced ERβ in some studies suppresses ERα-induced proliferation and transcriptional activity while also inducing independent transcriptional and functional changes [40, 41, 59–62].